Latest News

Houston, Texas – Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumor at the time of surgery and promising long-term survival, according to Phase II trial results published today in Nature Cancer by researchers at The University of Texas MD Anderson Cancer Center. After treatment...
TRENTO, Italy – “New windows of knowledge on ALS that pave the way for innovative possibilities in diagnosis, prognosis, and therapy.” With these words, researcher Manuela Basso summarizes the significance of a newly published study that deepens understanding of Amyotrophic Lateral Sclerosis (ALS), particularly the molecular mechanisms behind its slower-progressing...
Salt Lake City, Utah – Scientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer (TNBC), a particularly aggressive disease. Their research, published in JCO...